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By recruiting signaling proteins into complexes, 
adaptor molecules create nodes of regulation 
and  activity.  CD2AP  (alternatively  named 
CMS), the founding member of the CD2AP/
CIN85 family of adaptor proteins, was initially 
isolated in a yeast interaction screen as a bind-
ing partner of CD2 expressed on T cells (Dustin 
et al., 1998). Subsequently, its mammalian ho-
mologue CIN85 (Cbl interacting protein of   
85 kD) was identified as a partner of the E3 ubiq-
uitin ligase Cbl (Take et al., 2000). CIN85 con-
tains three Src homology 3 (SH3) domains at 
the N terminus that recognize an atypical pro-
line-arginine motif (PX(P/A)XXR), a central 
proline-rich region acting as an interaction mod-
ule for other SH3 domain–containing proteins, 
and a coiled-coil domain in the C terminus 
(Dikic, 2002; Fig. 1 A). CIN85 is expressed in 
almost all the tissues, where at least 10 different 
isoforms are differentially expressed in each tissue 
(Gout et al., 2000; Take et al., 2000). For instance, 
extra long and long isoforms (CIN85-xl, and 
CIN85-l)  are  expressed  abundantly  in  nerve 
systems, whereas in immune systems CIN85-l 
and CIN85-A isoforms are expressed domi-
nantly (Fig. 1 C; Shimokawa et al., 2010).
Based  on  coimmunoprecipitation  experi-
ments, colocalization studies, and in vitro protein–
protein interaction assays using fibroblasts, it   
has been proposed that CIN85 primarily func-
tions in endocytosis to down-regulate receptor 
tyrosine kinase activity (Dikic and Giordano, 
2003). According to this model, CIN85 consti-
tutively  associates  with  endophilin  and,  on 
stimulation with growth factors such as epider-
mal growth factor, complexes with Cbl to medi-
ate receptor down-regulation (Petrelli et al., 2002; 
Soubeyran  et  al.,  2002). The  same  mechanism   
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CIN85, an adaptor protein which binds the C-terminal domain of tyrosine phosphorylated 
Cbl and Cbl-b, has been thought to be involved in the internalization and subsequent 
degradation of receptors. However, its physiological function remains unclear. To determine 
its role in B cells, we used Mb1-cre to generate mice with a B cell–specific deletion of 
CIN85. These mice had impaired T cell–independent type II antibody responses in vivo and 
diminished IKK- activation and cellular responses to B cell receptor (BCR) cross-linking  
in vitro. Introduction of a constitutively active IKK- construct corrected the defective 
antibody responses as well as cellular responses in the mutant mice. Together, our results 
suggest that CIN85 links the BCR to IKK- activation, thereby contributing to T cell–
independent immune responses.
©  2011  Kometani  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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strategy with CIN85 as a bait, Watanabe et al. (2000) had pre-
viously  identified  BLNK  as  a  CIN85  interacting  protein. 
BLNK is a key adaptor molecule in BCR signaling and sub-
sequent B cell responses (Fu et al., 1998; Goitsuka et al., 1998; 
Wienands et al., 1998), which prompted us to hypothesize 
that CIN85 could play a significant role upstream and/or 
downstream of BLNK in the BCR signaling context. Before 
addressing this issue, we first examined which CIN85 iso-
form is expressed in B cells because several isoforms of 
CIN85, generated by different promoter usage and alterna-
tive  splicing,  had  already  been  reported  (Buchman  et  al., 
2002; Shimokawa et al., 2010). Western blotting analysis using 
an antibody raised against a C-terminal region of CIN85, 
common to all isoforms, detected two protein species in 
lysates of splenic B cells (Fig. 1 C). We concluded that the 
larger and smaller isoforms represent CIN85-l and CIN85-
A, respectively, because transcripts generating these two 
isoforms were detected in splenic B cells (Fig. S1 A) and 
because expression of cDNAs encoding the two isoforms in 
293T cells gave rise to proteins that co-migrated with the   
endogenous CIN85 proteins in splenic B cells (Fig. S1 B).
In agreement with the previous data that both CIN85-l 
and CIN85-A transcripts are expressed in various immune 
cell lineages, we found their expression not only in B cells but 
also in macrophages, DCs, and T cells in the spleen. Because 
B cells can be divided into several subsets based on their de-
velopmental stage or location, we examined expression of the 
two transcripts in each subpopulation. CIN85-l mRNA was 
higher in naive follicular (FO) and marginal zone (MZ) B cells 
in the spleen relative to developing B cells (pro–/pre–B and 
immature B cells) in the BM. We also observed significantly 
lower levels of CIN85-l and CIN85-A transcripts in iso-
lated germinal center (GC) B cells and in splenic B cells acti-
vated in vitro with anti-IgM, anti-CD40 antibody, IL-4, or 
toll-like receptor ligands (Fig. S1 A). CD2AP was also ex-
pressed in splenic B cells, as determined by quantitative (q) 
PCR and Western blotting analysis (Fig. S1, A and C).
also appears to operate in immune cells. CIN85 overexpression 
in the RBL-2H3 rat mast cell line accelerated the redistribu-
tion of engaged FcRI complexes, their sorting in early 
endosomes, and their delivery to a lysosomal compartment 
for degradation (Molfetta et al., 2005). Consequently, FcRI-
mediated degranulation was impaired. In addition to affecting 
endocytosis, overexpression of CIN85 in the RBL-2H3 was 
also reported to decrease the protein level of Syk, an effect 
presumably mediated through Cbl (Peruzzi et al., 2007). Over-
all, these data indicate that CIN85 plays a negative role in the 
context of FcRI signaling, consistent with the model estab-
lished in fibroblasts.
In contrast to the mast cell line data, a positive role for CIN85 
in pre-TCR signaling has been recently suggested. The cyto-
plasmic tail of pre–TCR- possesses a poly-proline-arginine 
sequence that interacts in vitro with SH3 domains of CD2AP, 
as well as CIN85, and deletion of the pre–TCR- CD2AP/
CIN85-binding motif impaired pre-TCR–mediated calcium 
mobilization in Jurkat T cells (Navarro et al., 2007). Because 
both CD2AP and CIN85 are recruited to the cytoplasmic 
domain of the pre–TCR- chain, it is likely that both CIN85 
and CD2AP act downstream of the pre-TCR to promote 
pre-TCR signaling. Thus, collectively with its functions in 
mast cells, CIN85 may mediate distinct biological outcomes 
that depend on the cell types and developmental stages of 
each cell type.
To test the physiological function of CIN85 in B lineage 
cells,  we  have  generated  B  cell–specific  CIN85  knockout 
mice. In this paper, we report that CIN85 links the BCR to 
IKK-/NF-B activation, thereby contributing to T cell– 
independent immune responses.
RESULTS
Expression of CIN85 in B lineage cells
During a yeast two-hybrid screen for BLNK (alternatively 
named SLP-65 or BASH) interacting proteins, we found that 
one of the clones isolated encoded CIN85. Using a reverse 
Figure 1.  Generation of CIN85 bKO mice.  
(A) CIN85-l and CIN85-A contain three or two SH3 
domains, respectively. Both isoforms contain a proline-
rich region and a coiled-coil (CC) domain. A schematic of 
CIN85 WT and floxed allele is shown. Exon 5 is flanked by 
two loxP sites. Arrows indicate primer position for PCR. 
(B) BM pre–B cells and immature B cells (Pre/Immat.) or 
spleen B cells or T cells from mb1-Cre; CIN85wt/Y (control) 
or mb1-Cre; CIN85fl/Y (CIN85 bKO) mice were sorted. 
CIN85 is located on the X chromosome and Y indicates  
Y chromosome. DNA was extracted from sorted cells and 
the deletion efficiency was assayed by PCR. The template 
DNA was serially diluted. (C) Inactivation of the CIN85 
was confirmed by Western blotting in spleen B cells and 
T cells. Migration of molecular mass markers is shown on 
the left side. The membrane was stripped and reprobed 
with anti-GAPDH antibody. Representative data of three 
independent experiments are shown.JEM Vol. 208, No. 7 
Article
1449
study, mb1-cre; CIN85wt/Y mice were 
used as control mice. It was previously 
reported that mb1 is transcribed, at 
least to some extent, in thymic T cells. 
Probably because of this, 1% of the 
CIN85 allele in splenic T cells was 
deleted; however, this leaky deletion 
had almost no effect on the total 
number of splenic T cells (Table I). 
Moreover, overall T cell development 
in mb1-cre; CIN85fl/Y mice was nor-
mal, as assessed by expression of CD4 
and CD8 of the thymocytes (Fig. 2).
B cell development in the mu-
tant mice was examined by multi-
parameter flow cytometry. In the BM 
of the mb1-cre; CIN85fl/Y mice, no 
gross developmental arrest was ob-
served; however, the total number of 
immature and recirculating B cells was reduced by 30% 
(Table I). Reflecting this decrease, the number of B220+  
B cells in the spleen was also reduced by 20% (Table I).   
Peripheral splenic B cells can be divided into immature (transi-
tional [T] 1, T2, and T3), mature FO, and mature MZ B cells, 
based on the expression of AA4.1, IgM, B220, CD23, and 
CD21 as described previously (Hardy and Hayakawa, 2001). 
The numbers of MZ B cells and immature T1 B cells were 
similar  between  control  and  mb1-cre;  CIN85fl/Y  mice, 
whereas the numbers of immature T2, immature T3, and 
mature FO B cells were reduced by 20% in the mutant 
mice. The B cell subset most affected in the mutant mice was 
the peritoneal B-1a B cells, which were approximately eight-
fold reduced. Thus, we conclude that CIN85 is required for 
normal development or maintenance of the peritoneal B-1a 
B cell compartment.
CIN85 is indispensable for B-1a B cell development
Because CIN85 is expressed in many different immune cells, 
to examine its B cell–intrinsic functions, we generated B cell–
specific knockout mice by crossing the mb1-cre mouse, 
which has a Cre recombinase transgene under the control of 
the mb1 promoter (mb1-cre; Hobeika et al., 2006), with a 
mouse in which Cin85 exon 5 is flanked by loxP sites 
(CIN85fl/Y; CIN85 is located on the X chromosome; Fig. 1 A). 
Exon 5 encodes an SH3 B region that is present in both 
CIN85-l and CIN85-A isoforms (Fig. 1 A). As expected, in 
these mice (mb1-cre; CIN85fl/Y; shown as CIN85 bKO or 
bKO in figure legends or figures, respectively) efficient dele-
tion of the targeted exon was seen in early B cells as well as 
peripheral splenic B cells (Fig. 1 B). Moreover, there was no 
detectable CIN85-l and CIN85-A protein in B cell extracts 
from the spleen of mb1-cre; CIN85fl/Y mice (Fig. 1 C). In this 
Table I.  Lymphocyte population in CIN85 bKO mice
Genotype BM (×106) Spleen (×106) PerC (×105)
Pro/Pre Immature Recirculate T1 T2 T3 FO MZ T cells B-1a
Control 8.9 ± 2.8 3.7 ± 1.4 3.4 ± 0.3 1.7 ± 0.3 3.6 ± 0.6 3.4 ± 1.0 24.6 ± 2.6 2.5 ± 0.5 21.5 ± 2.4 3.0 ± 0.5
bKO 8.9 ± 2.5 2.6 ± 1.0 2.3 ± 0.3 1.9 ± 0.3 2.8 ± 0.6 2.7 ± 0.8 19.5 ± 1.9 2.8 ± 0.5 19.4 ± 1.8 0.4 ± 0.2
Mean cell numbers of each population were calculated on the basis of total cell number and the percentages obtained from the flow cytometric analysis. Data are shown as 
mean ± SE (control, n = 7; bKO, n = 7). Pro, pro–B cells; Pre, pre–B cells, Immature, immature B cells; Recirculate, recirculating B cells; T1, T1 B cells; T2, T2 B cells; T3, T3 B cells;  
FO, FO B cells; MZ, MZ B cells; PerC, peritoneal cavity.
Figure 2.  B-1a cells in the peritoneal 
cavity are reduced in CIN85 bKO mice.  
B and T cell development in the BM, spleen, 
thymus, and peritoneal cavity (PerC) of con-
trol and CIN85 bKO mice were analyzed by 
flow cytometry. Numbers represent the 
percentages of cells within the gates. Repre-
sentative data of seven independent experi-
ments are shown.1450 CIN85 connects BCR to IKK- activation | Kometani et al.
mechanisms. In vivo, antigen accessi-
bility and its recognition are criti-
cal for initiating immune responses 
and, in this regard, the importance of 
MZ B cells in inducing TI-II im-
mune responses is well documented   
(Guinamard et al., 2000). Moreover, 
recent studies have demonstrated that MZ B cells rapidly cap-
ture complement-opsonized antigens, such as Ficoll, and de-
liver these antigens to the B cell follicles (Cinamon et al., 
2008). Thus, one possible explanation for the failure of mb1-
cre; CIN85fl/Y mice to elicit a TI-II response is that, despite 
the presence of MZ B cells, defined as CD21hiCD23lo (Fig. 2), 
these cells may not be able to capture Ficoll and subsequently 
transport it. However, our analysis renders this possibility un-
likely; MZ B cells in mb1-cre; CIN85fl/Y mice bound TNP-
Ficoll and transported it into the FO zones (Fig. 3, B and C).
Next, we analyzed the frequency of NP-specific B cells in 
the spleen on day 4 after the NP-Ficoll immunization. Before 
immunization, we found almost equal numbers of NP-reactive 
precursor B cells at frequencies consistent with previous results 
(Anderson et al., 2007). The percentage of NP-specific B cells 
in control mice increased from 0.06 to 0.32% after immuni-
zation, whereas there was only a barely detectable increase in 
mb1-cre; CIN85fl/Y mice (Fig. 3 D). Thus, CIN85 is most 
CIN85 is essential for normal T cell–independent  
immune responses
To determine whether CIN85 is essential for B cell responses 
to antigen in vivo, we immunized mice with 4-hydroxy-3-
nitrophenylacetyl (NP) coupled to chicken  globulin (CGG; 
NP-CGG) or Ficoll (NP-Ficoll) to elicit T cell–dependent 
(TD) and T cell–independent type II (TI-II) immune re-
sponses, respectively. The NP-specific TD IgM response was 
somewhat decreased in mb1-cre; CIN85fl/Y mice, whereas the 
IgG1 response was slightly increased. Moreover, the amount 
of higher affinity anti-NP IgG1, as assessed by using NP1-
BSA as a capture antigen in the ELISA assay, was not signifi-
cantly altered in the mutant mice (Fig. S2 A). GC formation 
took place normally in the mutant mice (Fig. S2 B).
In contrast, NP-Ficoll responses were barely detectable in 
mb1-cre; CIN85fl/Y mice, both in terms of NP-specific IgM 
and IgG3 (Fig. 3 A). Having demonstrated the importance of 
CIN85 in TI-II responses, we wished to address the underlying 
Figure 3.  TI-II but not TD responses are 
impaired in CIN85 bKO mice. (A) Control 
or CIN85 bKO mice were injected i.p. with 
50 µg NP-Ficoll. Sera from each mouse were 
collected before and every week after the 
immunization and the titers of anti-NP IgM 
(micrograms per milliliter) and IgG3 (arbi-
trary units [A.U.]) were measured by ELISA. 
Results are shown as the mean ± SD.  
**, P < 0.01. Each group consisted of at least 
four mice and the representative data of 
three repeated experiments are shown.  
(B and C) Mice were injected i.v. with PBS or 
100 µg TNP-Ficoll. After 30 min, spleens were  
collected and TNP-binding B cells were  
analyzed by flow cytometry (B) or  
immunohistochemistry (C). In the flow cyto-
metric analysis, FO B cells and MZ B cells 
were defined as CD21loCD23hi and  
CD21hiCD23lo cells, respectively. The gray histo-
gram represents PBS-injected control mice. 
Frozen sections were stained with anti–
MAdCAM-1 (green), TNP (red), and B220 
(blue) antibodies. Bars, 20 µm. (D) Spleen 
cells were collected from control or CIN85 
bKO mice 4 d after the i.p. injection with or 
without NP-Ficoll and analyzed by flow 
cytometry. NP-binding B cells were detected 
by staining with NIP-BSA-PE as described in 
the Materials and methods. Representative 
data of at least two independent experi-
ments are shown (B–D).JEM Vol. 208, No. 7 
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likely to be required for expansion of B cells in response to 
TI-II antigens in vivo.
CIN85 mediates BCR-induced B cell proliferation  
and survival in vitro
To further elucidate the function of CIN85, we directly as-
sessed  the  survival  and  proliferative  response  of  mb1-cre; 
CIN85fl/Y B cells to various stimuli in vitro. These mutant   
B cells exhibited defective survival after anti-IgM stimulation 
but not after other stimuli such as anti-CD40, LPS, IL-4, and 
BAFF (Fig. 4 A). We also assessed proliferation in response to 
anti-IgM stimulation with CFSE-labeled B cells from mutant 
and control mice. As shown in Fig. 4 B, the mb1-cre; CIN85fl/Y 
B cells essentially failed to divide at doses of 1 and 3 µg/ml 
anti-IgM. At saturating doses of 10 µg/ml anti-IgM, the 
mutant B cells began to divide but to a lesser extent than control 
B cells. No defects in proliferation were observed after stimu-
lation with LPS, CpG, and anti-CD40 + IL-4. The prolifera-
tion of mb1-cre; CIN85fl/Y B cells in response to anti-CD40 
ligation alone was somewhat decreased (Fig. 4 B).
Involvement  of  CIN85  in  BCR  signaling  was  further 
substantiated by imaging analysis using confocal microscopy. 
CIN85-GFP or BLNK-YFP was transduced to LPS-stimulated 
B cells, and BCR stimulation was performed by in vitro anti-
body cross-linking. Upon BCR stimulation, 90% of B cells 
demonstrated dense CIN85-GFP clusters colocalizing with 
BCR (n = 50, a representative of three independent experi-
ments; Fig. 4 C, top). This clustering was similar to that of 
BLNK translocation to the plasma membrane. 88% of the 
cells formed BLNK-YFP clusters with the BCR (n = 50,   
a representative of three independent experiments; Fig. 4 C, 
bottom). Thus, CIN85 participates specifically in BCR- 
mediated proliferation and survival.
CIN85 links the BCR to IKK
Because BCR stimulation induces multiple signaling path-
ways that culminate in cellular responses such as proliferation 
and survival, we wished to address which pathways are per-
turbed in mb1-cre; CIN85fl/Y B cells. As proximal events, we 
Figure 4.  BCR-induced proliferation and survival in vitro are  
impaired in CIN85 bKO mice. (A) Spleen B cells from each mouse were 
negatively purified with anti-CD43 magnetic beads and were cultured 
with 10 µg/ml anti-IgM F(ab’)2 fragment, 10 µg/ml LPS, 100 nM CpG,  
2 µg/ml anti-CD40 antibody, 10 ng/ml IL-4, or 50 ng/ml BAFF. After 48 h 
of culture, the proportion of live cells was enumerated as percentage of 
TO-PRO-3–excluding cells. Results represent the mean ± SD. n = 3.  
**, P < 0.01. (B) Purified spleen B cells were labeled with 5 µM CFSE. These 
CFSE-labeled cells were then cultured with 1, 3, or 10 µg/ml anti-IgM 
F(ab’)2 fragment, LPS, CpG, anti-CD40 antibody, or anti-CD40 plus IL-4 as 
indicated. After the culture for 72 h, cell division was measured by flow 
cytometry. Representative data from three independent experiments are 
shown (A and B). (C) Purified spleen B cells were stimulated with LPS for  
1 d, and cells were transduced with retroviruses encoding CIN85-GFP or 
BLNK-YFP. 2 d after the infection, microscopic analysis was performed. 
Top, CIN85 bKO B cells expressing CIN85-GFP (green) were stained by rat 
anti-IgM antibody (red), fixed before (top) or 2 min after (bottom) cross-
linking by anti–rat IgG antibody, and imaged by confocal microscopy. 
Histograms show fold fluorescent intensities of BCR (red) and CIN85-GFP 
(green) measured on the diagonal yellow line shown in the DIC images. 
Bars, 5 µm. Bottom, splenic B cells expressing BLNK-YFP (green) were 
stained by rat anti-IgM antibody (red), fixed before (top) or 2 min after 
(bottom) cross-linking by anti–rat IgG antibody, and imaged by confocal 
microscopy. More than 70% of BCR clusters were colocalized by BLNK or 
CIN85 on the cell surface (BLNK, 74.9 ± 11.6%; CIN85, 71.9 ± 19.9%; n = 20). 
Histograms show fold fluorescent intensities of BCR (red) and  
BLNK-YFP (green) measured on the diagonal yellow line shown in the DIC 
images. Bars, 5 µm. n = 50.
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Expression of constitutively active IKK- in B cells can 
substitute for some functions of CIN85
Having demonstrated the importance of CIN85 in BCR-
mediated canonical NF-B activation, we reasoned that the 
defects in mb1-cre; CIN85fl/Y mice should be restored by 
manipulations that enhance canonical NF-B signaling. To 
test this hypothesis, we crossed mb1-cre; CIN85fl/Y mice with 
mice in which a cDNA encoding constitutively active IKK-, 
preceded by a loxP-flanked STOP cassette, is knocked into 
the ubiquitously expressed ROSA26 locus (mb1-cre; CIN85fl/Y; 
R26StopflIKK-ca; Sasaki et al., 2006). As shown in Fig. 6 A, 
mb1-cre; CIN85fl/Y B cells from these mice express con-
stitutively active IKK-; however, the defect in B-1a cell   
development was not corrected (Fig. 6 B). In contrast, TI-II 
immune responses, as judged by anti-NP IgM titers, were   
almost completely restored by introduction of constitutively 
active IKK- (Fig. 6 C). Well correlated with restoration of 
TI-II immune response, in vitro BCR-mediated proliferation 
and survival were also restored (Fig. 6, D and E). Together, 
these results suggest that defective T cell–independent im-
mune responses could be, at least partly, explained by defec-
tive BCR-mediated canonical NF-B activation in mb1-cre; 
CIN85fl/Y mice.
DISCUSSION
Although a slightly decreased number of splenic T2, T3, and 
mature B cells was observed in the absence of CIN85, overall 
B-2  B  cell  development  took  place  normally.  In  contrast, 
there was a deficiency in the peritoneal B-1 cell compart-
ment. The selective B-1 deficiency fits with the idea that 
BCR cross-linking by self-antigen is required for mainte-
nance of this self-renewing B cell compartment (Hayakawa   
et al., 1999). In this regard, MZ B cells are thought to be simi-
larly selected by self-antigen to the B-1 population (Wen et al., 
2005), as there are shared characteristics between B-1 and 
MZ B cells, raising the question of why MZ B cells develop 
normally in the mutant mice. There are several, not necessarily 
first examined the status of overall tyrosine phosphorylation 
and calcium mobilization but detected no significant differ-
ences in either readout (Fig. S3 A). These results suggest that 
CIN85 is not essential for overall activation of proximal events 
of the BCR signaling cascade. Indeed, tyrosine phosphoryla-
tion status of Syk, BLNK, and PLC-2 was also not signifi-
cantly changed between control and mutant cells (Fig. S3 B).
NF-B, mitogen-activated protein kinase, and Akt path-
ways have been implicated in regulating B cell proliferation 
and survival; however, the phosphorylation status of Akt, Erk1, 
Erk2, and p38 after anti-IgM stimulation was not significantly 
altered in mb1-cre; CIN85fl/Y B cells (Fig. 5 A). In contrast, 
the level of IB phosphorylation was significantly decreased. 
The phosphorylation of JNK1 at 1 min was also decreased 
(Fig. 5, A and B). A defect in the canonical NF-B pathway in 
mb1-cre; CIN85fl/Y B cells was also confirmed by an in vitro 
kinase assay of the IKK complex. After a 5-min stimulation of 
BCR, the in vitro kinase activity of the IKK complex toward 
IB  was  significantly  impaired  in  mb1-cre;  CIN85fl/Y  
B cells (Fig. 5 B). In contrast to the canonical NF-B pathway, 
the  BAFF-mediated  noncanonical  NF-B  pathway  func-
tioned normally in mb1-cre; CIN85fl/Y B cells, as assessed by 
nuclear translocation of the p52 subunit of NF-B2 (Fig. S4). 
Thus, mutant B cells display a selective partial defect in BCR 
coupling to IKK signaling pathway.
Previous studies with the transformed RBL-2H3 mast 
cell line showed that overexpression of CIN85 decreases 
the Syk protein level and enhances FcRI-mediated endo-
cytosis (Peruzzi et al., 2007). Thus, we made a point of care-
fully checking the Syk protein level in mutant and control 
B cells but detected no significant difference (Fig. S5 A).   
To  examine  BCR-mediated  endocytosis,  we  took  two   
approaches: (1) in vitro BCR-mediated endocytosis; and   
(2) in vivo antigen-mediated endocytosis and subsequent anti-
gen presentation by B cells. No significant differences be-
tween mutant and control B cells were detected in these 
two assays (Fig. S5, B and C).
Figure 5.  BCR-dependent activation of 
the canonical NF-B pathway is impaired 
in CIN85 bKO B cells. (A) Purified spleen  
B cells were stimulated with 10 µg/ml anti-IgM 
F(ab’)2 for indicated times (minutes). The cells 
were lysed and subjected to SDS-PAGE. Trans-
ferred membranes were probed with the indi-
cated antibodies. (B) Spleen B cells from 
control or CIN85 bKO mice were stimulated 
with 10 µg/ml anti-IgM F(ab’)2 fragment for 
the indicated times. After stimulation, some 
of the cells were subjected to SDS-PAGE to 
measure the phosphorylation status of IB 
(top). Other cells were collected, precipitated 
by anti–IKK- antibody and subjected to an 
IKK kinase assay using GST-IB as a sub-
strate. The amount of phosphorylated GST-IB was detected by Western blotting as described in the Materials and methods (bottom). Phosphorylation 
status of IKK- was also analyzed by Western blotting. p-ERK was examined with whole cell lysate. Representative data of at least three independent 
experiments are shown.JEM Vol. 208, No. 7 
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Indeed, mice devoid of B-1 and MZ 
B cells, such as CD19/ mice, can 
still evoke TI-II responses (Rickert   
et al., 1995; Shih et al., 2002). Thus, 
the almost complete failure of mb1-
cre;  CIN85fl/Y  mice  to  respond  to 
TI-II antigens (Fig. 3 A) cannot be simply accounted for by 
the B-1 deficiency in the mutant mice.
In the case of MZ B cells, their importance for delivering 
complement-opsonized antigens such as Ficoll has been re-
cently appreciated (Cinamon et al., 2008). According to this 
model, MZ B cells shuttle between MZ and the B cell folli-
cles, thereby capturing blood-borne large antigens and sub-
sequently transporting them from the blood to splenic FO DCs, 
which then display the antigen to B cells. As shown in Fig. 3 C, 
this process appears to occur normally in the mutant mice, 
suggesting that antigen-specific B cells in the spleen are capa-
ble of recognizing cognate antigens. Therefore, the inability of 
the mutant mice to induce antibody responses is most likely 
explained by poor expansion and survival of antigen-specific 
MZ and FO B cells, as demonstrated in Fig. 3 D. In fact, BCR- 
mediated proliferation/survival and in vivo TI-II responses 
mutually exclusive, possibilities. First, the decreased signaling 
resulting from loss of CIN85 is still sufficient to promote   
the maturation and/or survival of the MZ subset but not the 
B-1 subset. Given the requirement for BAFF in development 
of the MZ, but not the B-1 subset (Schiemann et al., 2001), 
an alternative possibility is that the BAFF-R signal might 
compensate  for  the  decreased  BCR-mediated  signal  in 
MZ B cells, thereby promoting their development. Indeed, 
the BAFF-R–mediated survival signal is normal in mb1-cre; 
CIN85fl/Y B cells (Fig. 4 A and Fig. S4).
TI-II antigens, which are typically derived from poly-
saccharides and consist of complex repeating units, drive B cell 
responses by extensive cross-linking of cognate BCRs. Al-
though B-1 and MZ B cells have been thought to be responsible 
for the initial TI-II response, FO B-2 B cells also participate 
in the overall TI-II antibody responses (Swanson et al., 2010). 
Figure 6.  Impaired TI-II responses in 
CIN85 bKO mice are restored by intro-
duction of constitutively active IKK-. 
(A) Schematic design of the experiment. In 
the presence of Cre, exon 5 of Cin85 is de-
leted and Flag-IKK-ca is expressed. To 
confirm the expression of FLAG-tagged IKK-
ca, spleen B cells from control (Co) and 
CIN85 bKO were subjected to Western blot-
ting. (B) Peritoneal cells from control, CIN85 
bKO, CIN85 control; R26IKKcaKI/wt, and 
CIN85 bKO; R26IKKcaKI/wt mice were ana-
lyzed by flow cytometry. Numbers indicate 
the percentages of B-1a cells within the 
gate. (C) 3 × 106 purified spleen B cells from 
mice of indicated genotypes were injected  
i.v. into Rag1/ mice. On the next day, 50 µg 
NP-Ficoll was injected i.p. Sera were col-
lected 14 d later and the anti-NP IgM titer 
was measured by ELISA. Circles represent 
each titer and black bars represent the 
means. *, P < 0.05 (D) Purified spleen B cells 
from each genotype were cultured with 
medium alone or anti-IgM F(ab’)2 fragment 
for 48 h and the proportion of live cells 
were enumerated using TO-PRO-3. Data are 
shown as the mean ± SD. **, P < 0.01  
(E) Spleen B cells of indicated genotypes 
were labeled with 5 µM CellTrace violet and 
cultured with medium alone or anti-IgM 
F(ab’)2 fragment for 72 h and fluorescence 
intensity was measured by flow cytometry. 
Each group consisted of three mice (B and C) 
and representative data of three indepen-
dent experiments are shown (D and E).1454 CIN85 connects BCR to IKK- activation | Kometani et al.
MALT1, and TAK1 (Shinohara and Kurosaki, 2009), it is rea-
sonable to speculate that CIN85 interacts with such com-
plexes, directly or indirectly.
The precise biochemical mechanism by which CIN85 
activates IKK- remains unclear. One possibility is that the 
protein–protein interaction motifs of CIN85 might allow it 
to recruit additional signaling molecules, such as CARMA1, 
Bcl10, and MALT1, that could mediate IKK- activation di-
rectly or indirectly. Considering that CIN85 was recruited to 
the plasma membrane quite rapidly after BCR cross-linking, 
these interactions might have two consequences: membrane 
recruitment of CIN85 partners and their conformational 
changes. With regard to membrane recruitment, a role for the 
SH3 domain of CARMA1 was strongly implicated by studies 
using a lack-of-function CARMA1 mutant in the Jurkat   
T cell line (Wang et al., 2004). Thus, the proline-rich region of 
CIN85 might contribute to its association with the CARMA1 
SH3 domain and its subsequent membrane recruitment. 
When we used a lower concentration of anti-IgM compared 
with Fig. 4 C, we could not observe significant association 
between BCR and CIN85 (not depicted). This suggests that 
only strong BCR signal, such as in the case of TI-II responses, 
utilizes CIN85 for membrane recruitment of its partner mol-
ecules, whereas the weak signal, such as tonic BCR signal, 
might not necessarily require CIN85 (Lam et al., 1997; Monroe, 
2006), providing the potential explanation of why develop-
ment of mature FO B cells was only marginally affected in 
the absence of CIN85.
In addition to the conventional protein–protein inter-
actions mentioned in the previous paragraph, given the recent 
evidence that the SH3 C domain of CIN85 can function as 
an ubiquitin-binding domain (UBD; Bezsonova et al., 2008), 
CIN85 might exert its function through binding to ubiqui-
tinated proteins. Indeed, ubiquitination of IKK- and TRAF6 
has already been reported in the context of antigen receptor 
signaling being important for NF-B activation (Sun et al., 
2004). In addition, several NF-B components, for instance, 
TAK1-binding protein TAB2, are known to contain the UBD 
(Kanayama et al., 2004). Thus, it is possible that the CIN85 
UBD contributes to the assembly of complexes with targets 
such as IKK- and TRAF6, which are reversibly and cova-
lently modified by specific ubiquitin chains in the BCR sig-
naling context. It is also important to note that CIN85, like 
CD2AP, is capable of facilitating actin polymerization by in-
hibiting actin-capping proteins (Hutchings et al., 2003). Given 
the importance of actin cytoskeleton dynamics in NF-B sig-
naling (Legrand-Poels et al., 2007), deregulation of this pro-
cess  might  occur  in  mb1-cre;  CIN85fl/Y  B  cells,  possibly 
leading to defective NF-B signaling.
Assuming that CIN85 and CD2AP have redundant func-
tions, the question arises of why T cells lacking CD2AP show 
enhanced TCR-mediated proliferation. It has been observed 
that both CIN85 and CD2AP can bind to BLNK but not 
SLP-76 (Wienands, J., personal communication). Because 
BCR and TCR use BLNK or SLP-76, respectively, as a criti-
cal signaling molecule, it is possible that there is a preferential 
were restored by introduction of a constitutively active B cell–
specific IKK- in the mutant mice. Despite restoration of 
TI-II responses by active IKK-, B-1 B cell was not rescued. 
Assuming that an optimal intensity of NF-B signal is required 
for B-1 B cell development, it is possible that the intensity of 
NF-B signaling induced by our IKK- mutant might be too 
strong, thereby interfering with B-1 B cell development.   
An alternative possibility is that the canonical NF-B pathway is 
necessary, but not sufficient, for the development of B-1 B cells 
and that other pathways, such as JNK1, are also required.
Based on studies of 293T cells, after receptor tyrosine kinase 
activation, Cbl-CIN85 interaction is thought to be essential 
for the promotion of the initial steps of endocytosis and 
pinching off of the endocytic vesicles (Dikic, 2002). Cbl, one 
of the RING-type E3 ubiquitin ligases, is recruited to active 
tyrosine phosphorylated PTKs through its SH2 domain and 
ubiquitinated the receptors, which causes their endocytic- 
dependent degradation (Joazeiro et al., 1999). In addition, the 
interaction of Cbl with PTKs also induces tyrosine phos-
phorylation of Cbl, which unmasks its proline-rich determi-
nants that can then interact with SH3 domains of CIN85 
(Szymkiewicz et al., 2002). The association between Cbl and 
CIN85 is required for ligand-induced mono-ubiquitination 
of CIN85, which has been thought to be important for rec-
ognition of proteins of the endocytic machinery. This mecha-
nism has been shown to operate in physiological settings   
as well. By using neuron-specific CIN85 knockout mice, 
Shimokawa et al. (2010) have recently demonstrated the in-
volvement of CIN85 in endocytosis of the D2 dopamine re-
ceptor (D2DR), which belongs to the seven-transmembrane 
G protein–coupled receptor superfamily. But, in contrast to 
the D2DR, endocytosis of the D1 dopamine receptor was 
not affected by the loss of CIN85, suggesting the coexistence 
of CIN85-dependent and -independent mechanisms. Thus, 
considering the previous evidence that BCR down-modulation 
and Ig ubiquitination are inhibited in Cbl/Cbl-b/  
B cells (Kitaura et al., 2007), one possible interpretation for the 
apparently normal in vitro BCR internalization in mb1-cre; 
CIN85fl/Y B cells is that the BCR utilizes the Cbl-dependent 
but CIN85-independent mechanism. As discussed later in 
this section, this might be caused by the preferential associa-
tion of CIN85 to BLNK rather than to Cbl/Cbl-b in the 
BCR signaling context. Our results nevertheless allow for the 
alternative possibility that CIN85 and CD2AP participate,   
redundantly, in BCR endocytosis.
Our studies indicate that CIN85 has a positive role in 
BCR-mediated survival and proliferation by participating   
in canonical NF-B signaling. Although PLC-2 and sub-
sequent PKC- activation are involved in BCR-mediated 
NF-B activation (Saijo et al., 2002; Su et al., 2002), the ap-
parently normal tyrosine phosphorylation status of PLC-2 
and subsequent calcium mobilization in mb1-cre; CIN85fl/Y 
B cells suggest that CIN85 affects canonical NF-B activation 
independently of PLC-2/PKC-. Thus, given the previous 
evidence  that  defects  in  BCR-mediated  NF-B  signaling 
pathways are induced by mutations in CARMA1, Bcl10, JEM Vol. 208, No. 7 
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immunized i.p. with 50 µg NP-Ficoll. Sera were collected before and   
every week after the immunization and anti-NP IgM titers were measured 
by ELISA.
ELISA. 96-well flat-bottom plates were coated with 2 µg/ml NP10-BSA 
followed by blocking with 0.5% BSA in PBS. Serially diluted samples were 
incubated at 4°C for 1 d. After washing with PBS/0.5% Tween-20, horseradish 
peroxidase–conjugated anti–mouse IgM or IgG3 antibodies (Southern-
Biotech) were appropriately diluted and added to the wells. SureBlue (KPL) 
was used as the substrate and absorbance at 450 nm was measured using a 
microplate reader (Bio-Rad Laboratories). For detecting high-affinity anti-
NP IgG1 antibody, NP1-BSA was used as a capture antigen.
In vitro B cell culture. B cells were purified from the splenocytes using 
anti-CD43 microbeads and AutoMACS (Miltenyi Biotec). Collected cells 
were labeled with 5 µM CFSE (Dojindo) or CellTrace violet (Invitrogen) at 
37°C for 20 min. Labeled cells were cultured in RPMI1640 supplemented 
with 10% FBS, 50 µM 2-ME, and penicillin/streptomycin. Anti-IgM F(ab’)2 
(Jackson ImmunoResearch Laboratories), LPS (Sigma-Aldrich), CpG, anti-
CD40 (BD), and IL-4 (R&D Systems) were added as indicated. After 72 h of 
culture, cell division was measured by FACSCanto II. For analyzing cell 
viability,  negatively  purified  spleen  B  cells  were  cultured  with  anti-IgM 
F(ab’)2, LPS, CpG, anti-CD40, IL-4, or BAFF (R&D Systems). After 48 h of 
culture, the dead cells were labeled with TO-PRO-3 (Invitrogen) and the 
proportion of the live cells was enumerated as the percentage of TO-PRO-3–
negative cells.
Western blotting. Negatively purified spleen B cells were stimulated with 
10 µg/ml anti-IgM F(ab’)2 for the indicated periods and lysed with RIPA 
buffer. Cell lysates were boiled with SDS sample buffer and subjected   
to SDS-PAGE followed by transfer to PVDF membranes (Millipore). The 
membranes were blocked and incubated with the following antibodies to the 
following antigens: phospho IB, phospho ERK, phospho p38, phospho 
AKT (Ser473), phospho BLNK, BLNK, and phospho Syk (Cell Signaling 
Technology); IB, ERK1, ERK2, p38, JNK1/3, AKT, Syk, PLC-2, and 
phospho IKK- (Santa Cruz Biotechnology, Inc.); phospho JNK (Promega); 
IKK- (BD); and GAPDH and phosphotyrosine (Millipore). Anti-CIN85 
polyclonal antibody was obtained by immunizing rabbits with CIN85 peptide-
conjugated glutathione S-transferase (GST) as described previously (Oh-hora 
et al., 2003). Anti-CD2AP antibody was provided by A. Shaw (Washington 
University School of Medicine, St. Louis, MO). Then the membranes were 
incubated with the appropriate alkaline phosphatase-conjugated secondary 
antibody, followed by detection with a chemiluminescent substrate (Milli-
pore). The IKK kinase assay was performed as previously described (Shinohara 
et al., 2007). In brief, spleen B cells from the control or CIN85 bKO mice 
were stimulated with 10 µg/ml anti-IgM F(ab’)2 fragment for the indicated 
times. After stimulation, cells were lysed and the IKK complex was precipi-
tated with anti–IKK- antibody. IKK kinase activity was measured using 
GST-IB as a substrate. The amount of phosphorylated GST-IB was de-
tected by Western blotting.
Quantitative  RT-PCR.  Total  RNA  was  extracted  using  TRIZOL   
(Invitrogen) according to the manufacturer’s instructions. DNase I (Invitrogen)– 
treated  RNA  was  reverse  transcribed  using  Super  Script  III  (Invitrogen). 
Quantitative  PCR  was  performed  using  SYBR  Green  (Invitrogen)  and 
ABI Prism 7000 (Applied Biosystems). The following primers were used: 
5-GTGGAGGCCATAGTGGAGTT-3  and  5-CACGCTGATTGT-
CAGCTCAT-3  (Cin85-l);  5-CCCACAGACTTGCCTGAGA-3  and 
5-ACTGGATACATCGTGCATGG-3  (Cin85-A);  and  5-GCTCT-
GTGAAACTTCGGACA-3  and  5-CCCAGAGGCTGTAGGATTA-
AAG-3 (Cd2ap).
Analysis of B cell function. To examine the BCR-mediated calcium re-
sponse, purified B cells were loaded with Indo-1 AM (Dojindo) and Pluronic 
F-127 (Invitrogen) at 37°C for 45 min. Cells were stimulated with 10 µg/ml 
association of CIN85/CD2AP with BLNK in the BCR 
signaling context, thereby allowing both CIN85 and CD2AP 
to participate in NF-B activation, whereas in the case of 
TCR signaling, CIN85 and CD2AP associate with Cbl, 
thereby coupling them to an endocytotic pathway. Thus,   
depending on their binding partners, CIN85 and CD2AP 
could induce distinct biological outcomes. As an extension of 
this hypothesis, skewing the association of CIN85 and CD2AP 
toward Cbl in anergic anti-HEL B cells could explain why 
these cells shut off NF-B and JNK signaling and display an 
enhancement of endocytosis (Jun and Goodnow, 2003; Bléry 
et al., 2006).
MATERIALS AND METHODS
Mice. To generate Flox-CIN85 mice, a PCR-amplified Cin85 exon 5 con-
taining genomic fragment was flanked with two loxP sites and subcloned 
into a vector that contained a neomycin resistance gene, a diphtheria toxin A 
gene, and a 5.7-kbp 5 and a 2.0-kbp 3 homology Cin85 arm. The targeting 
vector was electroporated into C57BL/6 background Bruce4 embryonic 
stem cells (Köntgen et al., 1993) and selection was performed with G418 
(Invitrogen). Correctly targeted clones were identified by Southern blotting. 
The neomycin resistant gene was removed by transiently transfecting a Cre 
expression vector as described elsewhere (Yamada et al., 2008). Targeted ES 
clones were injected into blastocysts from BALB/c mice to obtain chimeric 
mice. These chimeric mice were then crossed with C57BL/6 mice to obtain 
germline transmitted animals. To generate B cell–specific CIN85 knockout 
mice, floxed mice were crossed with mb1-Cre knockin (KI) mice (Hobeika 
et al., 2006). Mb1-Cre knockin mice were provided by E. Hobeika and   
M. Reth (Max Planck Institute for Immunobiology, Freiburg, Germany). 
Rosa26-stop-FLAG-IKK-ca mice have been described previously (Sasaki 
et al., 2006). Mice were maintained under specific pathogen-free conditions. 
All the protocols for animal experiments were approved by the RIKEN 
Animal Research Committee.
Flow cytometric analysis. Single cell suspensions lysed of red blood cells 
were stained with fluorochrome-conjugated antibodies. Stained cells were 
analyzed with a FACSCalibur or FACSCanto II (BD). Anti-AA4.1, B220, 
Fas, GL7, IgD, IgM, MHC class II, CD3, CD4, CD5, CD8, CD21, CD23, and 
CD86 antibodies were purchased from BD, eBioscience, or BioLegend. 
NP-binding B cells were detected using (4-hydroxy-5-indo-3-nitrophenyl)acetyl 
(NIP)–BSA-PE.
For the detection of TNP-Ficoll binding cells, spleen cells were recov-
ered from the mice injected with 100 µg TNP-Ficoll i.v. These cells were 
then stained with biotin-conjugated anti-TNP antibody (BD) in combina-
tion with streptavidin-FITC and analyzed using a FACSCanto II.
Immunohistology. Small pieces of spleen were embedded in OCT com-
pound (Sakura) and frozen at 80°C. Frozen sections (8 µm) were fixed and 
stained with Alexa Fluor 488–conjugated anti–MAdCAM-1 (BioLegend), 
biotin-conjugated anti-TNP, Alexa Fluor 647–conjugated B220 antibodies 
(BD), and Alexa Fluor 546–conjugated streptavidin (Invitrogen). Images were 
obtained using BIOREVO (Keyence).
Induction of immune responses. For measuring TI-II antigen responses, 
mice were immunized with 50 µg NP28-Ficoll (Biosearch Technologies) i.p. 
To examine the TD antigen response, 100 µg NP-CGG precipitated with 
Imject Alum (Thermo Fisher Scientific) was injected i.p. 6 wk later, 50 µg of 
soluble NP-CGG was injected i.p. to induce recall responses. TI-II response 
in ROSA26-stop-FLAG-IKK-ca mice was examined by an adoptive trans-
fer experiment. In brief, B cells were purified from the spleen of these mice 
by depletion of activated B cells and non–B cells with anti-CD43 microbeads 
using  autoMACS  (Miltenyi  Biotec)  and  3  ×  106  of  purified  cells  were   
injected into Rag1/ mice i.v. On the next day, the recipient mice were   1456 CIN85 connects BCR to IKK- activation | Kometani et al.
uncoupling from NF-B in B cell clonal anergy. J. Exp. Med. 203:1773–
1783. doi:10.1084/jem.20060552
Buchman, V.L., C. Luke, E.B. Borthwick, I. Gout, and N. Ninkina. 2002. 
Organization of the mouse Ruk locus and expression of isoforms in 
mouse tissues. Gene. 295:13–17. doi:10.1016/S0378-1119(02)00821-1
Cinamon, G., M.A. Zachariah, O.M. Lam, F.W. Foss Jr., and J.G. Cyster. 2008. 
Follicular shuttling of marginal zone B cells facilitates antigen transport. 
Nat. Immunol. 9:54–62. doi:10.1038/ni1542
Dikic,  I.  2002.  CIN85/CMS  family  of  adaptor  molecules.  FEBS  Lett. 
529:110–115. doi:10.1016/S0014-5793(02)03188-5
Dikic, I., and S. Giordano. 2003. Negative receptor signalling. Curr. Opin. Cell 
Biol. 15:128–135. doi:10.1016/S0955-0674(03)00004-8
Dustin, M.L., M.W. Olszowy, A.D. Holdorf, J. Li, S. Bromley, N. Desai, P. 
Widder, F. Rosenberger, P.A. van der Merwe, P.M. Allen, and A.S. Shaw. 
1998. A  novel  adaptor  protein  orchestrates  receptor  patterning  and 
cytoskeletal polarity in T-cell contacts. Cell. 94:667–677. doi:10.1016/ 
S0092-8674(00)81608-6
Fu, C., C.W. Turck, T. Kurosaki, and A.C. Chan. 1998. BLNK: a central 
linker protein in B cell activation. Immunity. 9:93–103. doi:10.1016/ 
S1074-7613(00)80591-9
Goitsuka, R., Y. Fujimura, H. Mamada, A. Umeda, T. Morimura, K. Uetsuka, 
K. Doi, S. Tsuji, and D. Kitamura. 1998. BASH, a novel signaling 
molecule preferentially expressed in B cells of the bursa of Fabricius.   
J. Immunol. 161:5804–5808.
Gout, I., G. Middleton, J. Adu, N.N. Ninkina, L.B. Drobot, V. Filonenko, G. 
Matsuka, A.M. Davies, M. Waterfield, and V.L. Buchman. 2000. Negative 
regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J. 
19:4015–4025. doi:10.1093/emboj/19.15.4015
Guinamard, R., M. Okigaki, J. Schlessinger, and J.V. Ravetch. 2000. Absence 
of marginal zone B cells in Pyk-2-deficient mice defines their role in the 
humoral response. Nat. Immunol. 1:31–36.
Hardy, R.R., and K. Hayakawa. 2001. B cell development pathways. Annu. 
Rev. Immunol. 19:595–621. doi:10.1146/annurev.immunol.19.1.595
Hayakawa, K., M. Asano, S.A. Shinton, M. Gui, D. Allman, C.L. Stewart,   
J. Silver, and R.R. Hardy. 1999. Positive selection of natural autoreactive 
B cells. Science. 285:113–116. doi:10.1126/science.285.5424.113
Hobeika,  E.,  S. Thiemann,  B.  Storch,  H.  Jumaa,  P.J.  Nielsen,  R.  Pelanda, 
and M. Reth. 2006. Testing gene function early in the B cell lineage 
in mb1-cre mice. Proc. Natl. Acad. Sci. USA. 103:13789–13794. doi:10 
.1073/pnas.0605944103
Hutchings, N.J., N. Clarkson, R. Chalkley, A.N. Barclay, and M.H. Brown. 
2003.  Linking  the T  cell  surface  protein  CD2  to  the  actin-capping 
protein CAPZ via CMS and CIN85. J. Biol. Chem. 278:22396–22403. 
doi:10.1074/jbc.M302540200
Itano, A.A., S.J. McSorley, R.L. Reinhardt, B.D. Ehst, E. Ingulli, A.Y. Rudensky, 
and M.K. Jenkins. 2003. Distinct dendritic cell populations sequentially pres-
ent antigen to CD4 T cells and stimulate different aspects of cell-mediated 
immunity. Immunity. 19:47–57. doi:10.1016/S1074-7613(03)00175-4
Joazeiro,  C.A.,  S.S. Wing,  H.  Huang,  J.D.  Leverson, T.  Hunter,  and Y.C.  
Liu. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, 
E2-dependent  ubiquitin-protein  ligase.  Science.  286:309–312.  doi:10 
.1126/science.286.5438.309
Jun,  J.E.,  and  C.C.  Goodnow.  2003.  Scaffolding  of  antigen  receptors  for   
immunogenic versus tolerogenic signaling. Nat. Immunol. 4:1057–1064. 
doi:10.1038/ni1001
Kanayama, A., R.B. Seth, L. Sun, C.K. Ea, M. Hong, A. Shaito, Y.H. Chiu, L. 
Deng, and Z.J. Chen. 2004. TAB2 and TAB3 activate the NF-kappaB 
pathway through binding to polyubiquitin chains. Mol. Cell. 15:535–548. 
doi:10.1016/j.molcel.2004.08.008
Kitaura, Y., I.K. Jang, Y. Wang, Y.C. Han, T. Inazu, E.J. Cadera, M. Schlissel, 
R.R. Hardy, and H. Gu. 2007. Control of the B cell-intrinsic tolerance 
programs by ubiquitin ligases Cbl and Cbl-b. Immunity. 26:567–578. 
doi:10.1016/j.immuni.2007.03.015
Köntgen, F., G. Süss, C. Stewart, M. Steinmetz, and H. Bluethmann. 1993. 
Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. 
Immunol. 5:957–964. doi:10.1093/intimm/5.8.957
Lam, K.P., R. Kühn, and K. Rajewsky. 1997. In vivo ablation of surface immuno-
globulin on mature B cells by inducible gene targeting results in rapid 
cell death. Cell. 90:1073–1083. doi:10.1016/S0092-8674(00)80373-6
anti-IgM F(ab’)2 and the fluorescence was detected using LSR (BD) as de-
scribed previously (Baba et al., 2008).
For measuring BCR internalization, B cells were incubated with 0.5, 1, 
or 5 µg/ml biotin-conjugated anti-IgM antibody (BD) on ice for 20 min. 
After washing with ice cold PBS, the cells were kept on ice or incubated 
at 37°C for indicated times followed by incubation with streptavidin- 
allophycocyanin (APC; BD) and analyzed using a FACSCanto II.
To examine in vivo antigen presentation by B cells, 100 µg NP-E-GFP 
(Itano et al., 2003; Pape et al., 2007) was injected i.p. into the mice. This con-
struct was generated by K.A. Pape and M.K. Jenkins (University of Minne-
sota Medical School, Minneapolis, MN). After 12 h, splenocytes were 
collected and antigen-presenting B cells were detected by incubation with 
biotin-conjugated YAe antibody (eBioscience), followed by staining with 
NIP-BSA-PE, anti-B220, and streptavidin-APC. The cells were analyzed using a 
FACSCanto II.
Subcellular  localization  of  CIN85.  Mouse  CIN85  was  fused  to  the   
N terminus of GFP or CFP and subcloned to pMXs retroviral vector. pMXs 
vector was provided by T. Kitamura (University of Tokyo, Tokyo, Japan). Puri-
fied B cells were cultured with 10 µg/ml LPS for 1 d, and GFP-fused CIN85 
or YFP-fused  BLNK  was  retrovirally  transduced  into  LPS-stimulated   
B cells. 2 d later after the infection, the cells were incubated with 2 µg/ml 
anti-IgM antibody followed by cross-linking with fluorochrome-conjugated 
anti–rat IgG antibody. The cells were fixed and imaged by confocal micros-
copy (Leica).
Statistical analysis. Statistical analyses were performed using two-tailed 
unpaired Student’s t test.
Online supplemental material. Fig. S1 shows the expression of CIN85 
and CD2AP in immune cells. Fig. S2 shows TD immune responses in CIN85 
bKO mice. Fig. S3 shows normal activation of BCR-proximal signaling mol-
ecules in CIN85 bKO mice. Fig. S4 shows BAFF-induced noncanonical   
NF-B activation in CIN85 bKO mice. Fig. S5 shows the effects of CIN85 de-
letion on protein degradation and internalization. Online supplemental material   
is available at http://www.jem.org/cgi/content/full/jem.20102665/DC1.
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